By the World Health Organization

Recent advances in the global landscape of hepatitis C diagnostics and treatments provides a powerful momentum in low‐ and middle‐income countries to scale up their public health response towards the elimination of viral hepatitis as a public health threat by 2030. This third global report highlights the impressive recent gains achieved by some highburden countries latest and the developments in the key enablers of a successful response – market conditions related to product availability, pricing and patents, access to diagnostics, norms and standards; national policy and regulatory environments; and options for leveraging efficiencies in service delivery. Join the World Health Organization (WHO) at a virtual event to launch the new 2020 report ‐ Accelerating access to hepatitis C diagnostics and treatment: Overcoming barriers in low‐ and middle‐income countries.

Register here


1. Opening remarks and introduction
2. Report 2020 Key Messages :

  • Evolving access landscape for a successful public health response - challenges and opportunities
  • Focus on access to diagnostics – a game-changer?
  • Highlights on intellectual property rights and HCV diagnostics and treatment

3. Panel session – voices and experiences from countries and organization’s working on access
4. Questions and Answers
5. Closing remarks     

Daniel Low-Beer, Global HIV, Hepatitis and STIs Programmes, World Health Organization

Presenters / Panelists

  • Dr. Minghui Ren, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, WHO
  • Dr Mariangela Simao, Assistant Director-General, Access to Medicines and Health Products (MHP), WHO
  • Meg Doherty, Director, Global HIV, Hepatitis and STIs Programmes (HHS), WHO
  • Françoise Renaud, Technical lead, WHO/HHS
  • Adriana Velazquez, Team Lead, Medical Devices, and Diagnostics WHO/MHP
  • Mercedes Perez Gonzales, Technical officer, Medical Devices and Diagnostics, WHO/MHP
  • Erika Duenas Loayaz, Technical officer, Intellectual Property Management, WHO/MHP
  • Olufunmilayo LESI, Team Lead, Global Hepatitis Programme, WHO/HHS
  • Janvier Serumondo, Director Hepatitis Program, Ministry of Health, Rwanda 
  • Ukraine
  • Charles Gore, Executive Director, Medicines Patent Pool 
  • Craig McClure, Senior Director, Viral Hepatitis, Clinton Health Access Initiative
  • Othman Mellouk, International Treatment Preparedness Coalition